SCM Lifescience develops high-purity, high-efficacy stem cell therapies using a proprietary layer separation culture method to address difficult-to-treat diseases. The company focuses on providing advanced cell therapy solutions that enhance treatment options for patients with challenging medical conditions.
Funding
$35M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many patients with difficult-to-treat diseases lack effective treatment options. Current cell therapies often suffer from low purity and efficacy, limiting their therapeutic potential.
Solution
SCM Lifescience develops high-purity, high-efficacy stem cell therapies for difficult-to-treat diseases. The company utilizes a proprietary layer separation culture method to isolate and culture high-purity stem cells, resulting in highly effective cell therapies. These therapies aim to provide advanced treatment solutions and enhance outcomes for patients with challenging medical conditions. SCM Lifescience focuses on cell therapies, immune cell therapies, and tissue engineering.
Target Audience
The primary target audience includes patients with difficult-to-treat diseases, as well as healthcare providers seeking advanced cell therapy solutions.
Features
- Proprietary layer separation culture method for isolating high-purity stem cells
- Development of cell therapies for a range of difficult-to-treat diseases
- Focus on enhancing treatment options for patients with challenging medical conditions
- cGMP manufacturing capabilities
- Development of tissue engineering products